(S1 (S (S (NP (NN NEMO)) (VP (VBZ stabilizes) (NP (NN c-Myc)) (PP (IN through) (NP (NP (JJ direct) (NN interaction)) (PP (IN in) (NP (DT the) (NN nucleus))))))) (. .)))
(S1 (S (S (NP (DT The) (NN transcription) (NN factor) (NN c-Myc)) (VP (VBZ is) (NP (NP (DT a) (JJ cellular) (NN oncoprotein)) (VP (ADVP (RB generally)) (VBN upregulated) (PP (IN in) (NP (NP (JJS most)) (PP (IN of) (NP (JJ human) (NNS cancers))))))))) (. .)))
(S1 (S (S (NP (NP (NN NF-kappaB) (JJ essential) (NN modulator)) (PRN (-LRB- -LRB-) (NP (NN NEMO)) (-RRB- -RRB-))) (VP (VBD caused) (NP (NP (NP (NN phosphorylation)) (CC and) (NP (NN stabilization))) (PP (IN of) (NP (NN c-Myc) (NN protein)))) (PP (IN in) (NP (DT the) (NN nucleus))) (PP (IN through) (NP (JJ direct) (NN interaction))))) (. .)))
(S1 (S (S (NP (DT The) (NN interaction)) (VP (VBD caused) (NP (NP (VBN reduced) (NN ubiquitination)) (PP (IN of) (NP (NN c-Myc)))) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (VBG ubiquitinating) (NN activity)) (PP (IN of) (NP (NN Fbw7)))) (PP (IN without) (S (VP (VBG blocking) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN c-Myc)) (CC and) (NP (NN Fbw7))))))))))))) (. .)))
(S1 (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (NN NEMO)) (VP (VBD enhanced) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ several) (VBN selected) (NN c-Myc) (NNS targets)))))) (. .)))
(S1 (S (S (PP (VBN Compared) (PP (TO to) (NP (NP (DT the) (JJ classical) (NN role)) (PP (IN as) (NP (NP (DT an) (JJ essential) (NN subunit)) (PP (IN for) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN IKK) (NN complex)))))))))) (, ,) (NP (NP (NN stabilization)) (PP (IN of) (NP (NN c-Myc))) (PP (IN by) (NP (JJ direct) (NN interaction)))) (VP (VBZ is) (NP (NP (DT a) (JJ unique) (NN function)) (PP (IN of) (NP (NN NEMO)))) (, ,) (S (VP (VBG representing) (NP (NP (DT a) (JJ new) (NN mechanism)) (S (VP (TO to) (VP (VB regulate) (NP (NN c-Myc) (NN activity)))))))))) (. .)))
